SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Creative Edge Nutrition Inc (OTCMKTS:FITX) released a letter to its shareholders pertaining to the details related with the re-filing of license application for judicial review. The purpose of the letter was to briefly address the dismissal of the license applications for Judicial Review filed in Canadian Federal Court.

The details

Creative Edge stated that in no way the rejection of the Application is an indication that it has abandoned its pursuit for judicial relief. Health Canada had rejected the company’s application license under the ‘MMPR Program’. The rejection is merely a procedural problem to fulfill certain procedural rules as led by the Court.

CEN Biotech

Creative Edge established CEN Biotech in 2013 as its partially owned subsidiary firm. It was created for the sole objective of providing the Canadian public with Pharma-grade medical cannabis under the MMPR program. The subsidiary submitted a comprehensive license application to become a LP of dried marihuana for medical purposes.

Another letter

Creative Edge has been releasing a series of letters to its shareholders to inform them about the latest happenings related with application under the MMPR program. In latest letter, the company said that CEN Biotech has been a target of tiresome attacks in past twelve months. It mentioned the name of a Canadian newspaper, The Globe and Mail, and stated it responsible for attacking the company.

The problems

Creative Edge Nutrition Inc (OTCMKTS:FITX) mentioned the name of Grant Robertson who is a reporter for The Globe and Mail responsible for the campaign of untruths and image distortion. The company said that a major part of attacks came from the mentioned newspaper. The objective was just to destroy the image and reputation of the company that management has created by strenuous efforts. The reporter made false accusations against Creative Edge and its subsidiary. On Thursday’s trading session, the stock price of Creative Edge dropped 16.67% to close the trading session at $0.00500.

SHARE
Previous articleLandstar Development Group Inc (OTCMKTS:LSDC) Contracts with Heptagon Seven
Next articleMinerco Resources Inc (OTCMKTS:MINE) To Launch VitaminFIZZ In UK Market
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.